1. Wilks AF. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989;86(5):1603–7.
2. FDA. FDA approves Xeljanz for rheumatoid arthritis 2012 [updated Nov. 6, 2012]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm327152.htm .
3. FDA. FDA approves first drug to treat a rare bone marrow disease 2011 [updated Nov. 16, 2011]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm280102.htm .
4. FDA. FDA approves Jakafi to treat patients with a chronic type of bone marrow disease 2014 [updated December 4, 2014]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425677.htm .
5. FDA. NADA 141–345 APOQUEL Oclacitinib Tablet Dogs 2013 [updated May 14, 2013]. http://www.fda.gov/downloads/AnimalV.../UCM363901.pdf .